对于血友病的RNA疗法的创新
Margaret V Ragni1, Stephen Y Chan2
1Division of Hematology Oncology, Department of Medicine, University of Pittsburgh, Hemophilia Center of Western Pennsylvania, Pittsburgh, PA.
Blood
|July 21, 2023
概括
RNA疗法为血友病治疗提供了一种新方法,有可能减少出血并改善生活质量. 这些先进的疗法,包括小干扰RNA和基因编辑,为遗传性出血障碍带来更好的结果.
科学领域:
- 血液学 血液学 血液学
- 基因治疗 基因治疗
- 在RNA治疗方面,RNA疗法.
背景情况:
- 目前的血友病治疗方法,包括基于因子和基因疗法,都有局限性.
- 基于RNA的治疗方法的开发代表了血友病管理的重大进步.
研究的目的:
- 审查血友病治疗当前的局限性.
- 探索新型RNA治疗血友病的进展和潜力.
主要方法:
- 针对小干扰RNA (siRNA) 治疗方法的审查,以凝块调节器为目标.
- 讨论CRISPR/Cas9基因编辑用于个性化的血友病治疗.
- 探索信使RNA (mRNA) 纳米粒子传递系统.
主要成果:
- RNA疗法显示出减少出血发作和因子依赖的潜力.
- 新型药物可以防止抑制剂的形成,并简化治疗方案.
- 这些进展旨在改善血液静止和整体生活质量.
结论:
- 基于RNA的疗法正在改变血友病的管理.
- 未来的发展有望减少关节出血,疾病和手术的需要.
- 对血液静止和血栓形成的更好理解将推动更好的遗传性出血障碍疗法.
相关概念视频
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
RNA Editing
9.1K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.1K
Microorganisms in Medicine and Therapeutics
60
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
60
Alternative RNA Splicing
21.4K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.4K
CRISPR
52.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.4K


